Comparison of Two Dosing Regimens of Temozolomide in Patients With Progressive or Recurrent Glioblastoma

NCT00941460 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide in both arms
DRUG: Temozolomide in both arms

Sponsor

Prof. Dr. Wolfgang Wick

Collaborators

[object Object]